United States
                       Securities and Exchange Commission
                              Washington, DC 20549

                                   FORM 10-QSB

                  Quarterly Report Under Section 13 or 15(d) of
                       the Securities Exchange Act of 1934


For the Quarter Ended                                     Commission File Number
June 30, 2003                                                            0-50218


                            EMPS RESEARCH CORPORATION
             (Exact name of registrant as specified in its charter)

                                      UTAH
          (State or other jurisdiction of incorporation or organization

                                   87-0669131
                      (I.R.S. Employer Identification No.)


              875 Donnor Way, Unit 705, Salt Lake City, Utah 84108
                    (Address of principal executive offices)

                                 (801) 582-1881
              (Registrant's telephone number, including area code)

         Securities registered pursuant to Section 12 (b) of the Act:

                                      None

         State the number of shares outstanding of each of the registrants
classes of common equity, as of the latest practicable date.

Common stock, par value $.001;                    3,300,000 shares outstanding
                                                      as of August 13, 2003

<PAGE>

                          PART I. FINANCIAL INFORMATION

Item 1.  Financial Statements
<TABLE>
<CAPTION>
                                              EMPS RESEARCH CORPORATION
                                            (A Development Stage Company)

                                                   BALANCE SHEETS

                                                       ASSETS

                                                                                        June 30,        December 31,
                                                                                          2003              2002
                                                                                      ------------      ------------
                                                                                       (Unaudited)
<S>                                                                                   <C>               <C>
CURRENT ASSETS:
     Cash                                                                             $     28,058      $     34,437
     Prepaid expenses                                                                        4,835             3,441
                                                                                      ------------      ------------
               Total Current Assets                                                         32,893            37,878
                                                                                      ------------      ------------

OTHER ASSETS
     Patents and deferred patent costs, net of amortization
       of $488 and $385                                                                      2,148             2,251
                                                                                      ------------      ------------

               Total Other Assets                                                            2,148             2,251
                                                                                      ------------      ------------

TOTAL ASSETS                                                                          $     35,041      $     40,129
                                                                                      ============      ============


                                        LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES:
     Accounts payable                                                                 $      1,460      $        719
     Franchise tax payable                                                                       -               100
     Deferred revenue                                                                       11,175            11,232
                                                                                      ------------      ------------
               Total Current Liabilities                                                    12,635            12,051
                                                                                      ------------      ------------

STOCKHOLDERS' EQUITY (DEFICIT):
     Common stock; $.001 par value, 50,000,000
          shares authorized, 3,300,000 and 3,300,000 shares
          issued and outstanding respectively                                                3,300             3,300
     Additional paid-in capital                                                             33,845            33,845
     Deficit accumulated during the development stage                                      (14,739)           (9,067)
                                                                                      ------------      ------------
               Total Stockholders' Equity (Deficit)                                         22,406            28,078
                                                                                      ------------      ------------
TOTAL LIABILITIES AND STOCKHOLDERS'  EQUITY                                           $     35,041      $     40,129
                                                                                      ============      ============


                   The accompanying notes are an integral part of these financial statements.

                                                        2
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
                                                  EMPTS RESEARCH CORPORATION
                                                 (A Development Stage Company)

                                                   STATEMENTS OF OPERATIONS
                                                          (UNAUDITED)


                                                       For the         For the            For the         For the
                                                    Three Months     Three Months       Six Months       Six Months     Cumulative
                                                        Ended           Ended              Ended           Ended        During The
                                                      June 30,         June 30,          June 30,         June 30,      Development
                                                        2003             2002              2003             2002           Stage
                                                      ---------        ---------         ---------       ---------      ---------
<S>                                                   <C>              <C>               <C>             <C>            <C>
REVENUE                                               $       -        $       -         $       -       $       -      $       -
                                                      ---------        ---------         ---------       ---------      ---------
EXPENSES
     General and administrative                           2,356              420             5,569             876         14,209
     Amortization expense                                    51               51               103             103            488
                                                      ---------        ---------         ---------       ---------      ---------
          Total Expenses                                  2,407              471             5,672             979         14,697
                                                      ---------        ---------         ---------       ---------      ---------

NET INCOME (LOSS) FROM OPERATIONS                        (2,407)            (471)           (5,672)           (979)       (14,697)

OTHER INCOME (EXPENSE)
     Grant revenue, net of grant expenses of
      $(2,335), $20,431, $57, $39,893,
      and $140,137                                            -                -                 -               -              -
     Interest income (expense)                                -               40                 -              (2)           (42)
                                                      ---------        ---------         ---------       ---------      ---------
          Total income (expense)                              -               40                 -              (2)           (42)
                                                      ---------        ---------         ---------       ---------      ---------

NET INCOME (LOSS)                                     $  (2,407)       $    (431)        $  (5,672)      $    (981)     $ (14,739)
                                                      =========        =========         =========       =========      =========

EARNINGS (LOSS) PER SHARE                             $   (0.00)       $   (0.00)        $   (0.00)      $   (0.00)     $   (0.00)
                                                      =========        =========         =========       =========      =========

WEIGHTED AVERAGE NUMBER OF
SHARES OUTSTANDING                                    3,300,000        3,000,000         3,300,000       3,000,000      3,070,000
                                                      =========        =========         =========       =========      =========


                                 The accompanying notes are an integral part of these financial statements.

                                                                      3
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
                                                  EMPS RESEARCH CORPORATION
                                                (A Development Stage Company)

                                                  STATEMENTS OF CASH FLOWS
                                                         (UNAUDITED)




                                                                                    For the         For the
                                                                                   Six Months      Six Months       Cumulative
                                                                                     Ended           Ended          During The
                                                                                    June 30,        June 30,       Development
                                                                                      2003            2002            Stage
                                                                                   ---------       ---------        ---------
<S>                                                                                <C>             <C>              <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
     Cash from grant                                                               $       -       $  31,852        $ 151,312
     Cash paid for interest                                                                -              (2)             (42)
     Cash paid for grant expenses                                                     (2,625)        (33,651)        (139,427)
     Cash paid for non grant expense                                                  (3,754)           (877)         (15,785)
     Cash paid for taxes                                                                   -            (100)            (100)
                                                                                   ---------       ---------        ---------
          Total cash used in operating activities                                     (6,379)         (2,778)          (4,042)
                                                                                   ---------       ---------        ---------
CASH FLOW FROM INVESTING ACTIVITIES:                                                       -               -                -
                                                                                   ---------       ---------        ---------
CASH FLOWS FROM FINANCING ACTIVITIES:
     Sale of common stock for cash                                                         -               -           32,100
                                                                                   ---------       ---------        ---------
          Total cash provided by financing activities                                      -               -           32,100
                                                                                   ---------       ---------        ---------
NET INCREASE (DECREASE) IN CASH                                                       (6,379)         (2,778)          28,058

CASH - BEGINNING OF PERIOD                                                            34,437           6,406                -
                                                                                   ---------       ---------        ---------
CASH - END OF PERIOD                                                               $  28,058       $   3,628        $  28,058
                                                                                   =========       =========        =========

RECONCILIATION OF NET INCOME (LOSS) TO NET CASH
  PROVIDED (USED) BY OPERATING ACTIVITIES

NET INCOME (LOSS)                                                                  $  (5,672)      $    (981)       $ (14,739)
                                                                                   ---------       ---------        ---------
Adjustment to reconcile net income (loss) to net
     cash provided (used) by operating activities
          Amortization of patent costs                                                   103             102              488
          Organization costs paid by issued common stock                                   -               -              264
          Patent write-off                                                                 -               -            2,145
          Change in assets and liabilities
            (Increase) in due to Government Grant                                          -          (8,041)               -
            (Increase) decrease in prepaid expenses                                   (1,394)              -           (4,835)
            Increase (decrease) in accounts payable                                      741           9,353            1,460
            Increase in due to parent                                                      -             120                -
            Increase (decrease) in franchise tax payable                                (100)           (100)               -
            Increase (decrease) in deferred revenue                                      (57)         (3,231)          11,175
                                                                                   ---------       ---------        ---------
                    Total Adjustments                                                   (707)         (1,797)          10,697
                                                                                   ---------       ---------        ---------
NET CASH PROVIDED (USED) BY OPERATING ACTIVITIES                                   $  (6,379)      $  (2,778)       $  (4,042)
                                                                                   =========       =========        =========

NONCASH TRANSACTIONS
     Common stock issued to pay for organization costs                             $       -       $       -        $     264
                                                                                   =========       =========        =========
     Forgiveness of payable to Parent for patent costs                             $       -       $       -        $   2,145
                                                                                   =========       =========        =========
     Commons stock issued for assignment of patents
       from Parent                                                                 $       -       $       -        $   2,636
                                                                                   =========       =========        =========


                   The accompanying notes are an integral part of these financial statements.

                                                          4
</TABLE>
<PAGE>

                           EMPS RESEARCH CORPORATION
                          (A Development Stage Company)

                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)

NOTE 1 - CONDENSED FINANCIAL STATEMENTS

         The Company, without audit, has prepared the accompanying financial
         statements. In the opinion of management, all adjustments (which
         include only normal recurring adjustments) necessary to present fairly
         the financial position, results of operation and cash flows at June 30,
         2003 and 2002 and for all periods presented have been made.

         Certain information and footnote disclosures normally included in
         financial statements prepared in accordance with generally accepted
         accounting principles have been condensed or omitted. It is suggested
         that these condensed financial statements be read in conjunction with
         the financial statements and notes thereto included in the Company's
         December 31, 2002 audited financial statements. The results of
         operations for the periods ended June 30, 2003 and 2002 are not
         necessarily indicative of the operating results for the full year.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

         Organization - EMPS Research Corporation (The Company) was organized
         under the laws of the State of Utah on January 31, 2001 and has elected
         a fiscal year end of December 31st. EMPS Corporation (Parent) formed
         the Company by giving cash and other consideration in exchange for all
         of the issued and outstanding shares of EMPS Research Corporation (See
         note 3). The Company was formed for the purpose of furthering
         development and marketing of patented technology for commercially
         separating nonmagnetic particulate material from other materials
         without heat or water. The Company has not commenced planned principle
         operations and is considered a development stage company as defined in
         SFAS No. 7. The Company has three patents having to do with the
         business purpose outlined above.

         Financial statements - The accompanying financial statements include
         only the accounts of EMPS Research Corporation and are not presented on
         a consolidated basis with EMPS Corporation which is its Parent Company.
         At December 31, 2002 EMPS Corporation owned 91% of the common stock of
         EMPS Research Corporation respectively. EMPS Research Corporation was
         spun-off from EMPS Corporation effective May 23, 2003. Certificates for
         the spin-off were issued July 31, 2003. The 3,000,000 shares of the
         Company owned by EMPS Corporation were distributed to shareholders of
         EMPS Corporation and at that date the Company is no longer a subsidiary
         of EMPS Corporation.

         Net Earnings Per Share - The computation of net income (loss) per share
         of common stock is based on the weighted average number of shares
         outstanding during the periods presented.

         Assignment of Patent Rights - The Company is amortizing its cost
         associated with the acquisition of its patents over a remaining life of
         12.8 years using the straight-line method. This life is the legally
         remaining protected lives of the patents.

         Income Taxes - Due to losses at June 30, 2003, and December 31, 2002
         and 2001, no provisions for income taxes has been made. There are
         deferred income taxes resulting from income and expense items being
         reported for financial accounting and tax reporting purposes in
         different periods. The difference arises from the accelerating of the
         write-off of organization costs for financial statement purposes as
         compared to amortizing over 60 months for tax purposes.

                                       5
<PAGE>

                            EMPS RESEARCH CORPORATION
                          (A Development Stage Company)

                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED

         Cash and Cash Equivalents - For purposes of the statement of cash
         flows, the Company considers all highly liquid debt instruments
         purchased with a maturity of three months or less to be cash
         equivalents. The Company did not have non-cash investing activities
         during the presented periods for 2003 and 2002.

         Use of Estimates - The preparation of financial statements in
         conformity with generally accepted accounting principles requires
         management to make estimates and assumptions that affect the reported
         amounts of assets and liabilities and disclosure of contingent assets
         and liabilities at the date of the financial statements and the
         reported amounts of revenues and expenses during the reporting period.
         Actual results could differ from those estimates.

         Grant revenue recognition - The DOE grant is funded on a cost
         reimbursement basis and payments received from the grant are treated as
         earned and recognized as revenue at the time expenditures reimbursable
         under the grant are made by the Company. The grant has provisions for
         advance payments. A grant receivable is recorded if expenditures exceed
         amounts received under the grant and deferred revenue is recorded if
         payments exceed costs expended under the grant.

NOTE 3 - EQUITY TRANSACTIONS

         On January 31, 2001, the Parent formed the Company as a wholly owned
         Subsidiary by giving cash and other consideration in exchange for
         1,000,000 shares of the Company's common stock. The Company was
         incorporated on January 31, 2001 in the State of Utah. At that time the
         Parent owned all of the issued and outstanding common shares of the
         Company (1,000,000 shares). The consideration given by the Parent to
         the Company for its shares was $2,100 of cash, payment of organization
         costs of $264 on behalf of the Company and the assignment of three
         Patents owned by the Parent to the Company at their book value
         (historical costs) at time of assignment in the amount of $2,636. Thus,
         the Parent paid a total price of $5,000 for the 1,000,000 shares of
         common stock of the Company.

         On November 29, 2002, the stockholder (Parent) approved a 3 for 1
         forward stock split of the issued and outstanding common shares of the
         Company. At the time of the stock split the number of shares authorized
         and the par value of the common shares remained unchanged. As a result
         of the split, 2,000,000 additional shares were issued, and additional
         paid in capital was reduced by $2,000. All references in the
         accompanying financial statements to the number of common shares and
         per-share amounts have been restated to reflect the stock split.

         On December 31, 2002, the Company sold 300,000 shares of its common
         stock for cash at $.10 per share for a total amount of $30,000. The
         shares were sold to Techgrand Company Ltd., a Hong Kong company, which
         owns shares of the common stock of the Company's Parent. At the
         completion of the transaction the Company was no longer a wholly owned
         subsidiary of EMPS Corporation.

         EMPS Research Corporation was spun-off from EMPS Corporation effective
         May 23, 2003. Certificates for the spin-off were issued July 31, 2003.
         The 3,000,000 shares of the Company owned by EMPS Corporation were
         distributed to shareholders of EMPS Corporation and at that date the
         Company is no longer a subsidiary of EMPS Corporation.

                                       6
<PAGE>

                            EMPS RESEARCH CORPORATION
                          (Development Stage Companies)

                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)

NOTE 4 - RELATED PARTY TRANSACTIONS

         The Company has no employees. As of June 30, 2003 and December 31, 2002
         no compensation was paid or accrued to any officers or directors of the
         Corporation due to the fact that it is of only nominal value. Starting
         in the first quarter of 2001 and through the second quarter of 2001,
         compensation was paid to the project manager of the government grant
         issued to the Company (see note 3) in the amount of $20,000. The
         project manager was a related party to the Company at the time of the
         payment.

         The Company is receiving free office space through a related Party. The
         value of the free rent to date has been of nominal value.

         The Company decided to abandon its continuation-in-part (CIP) patent
         application during the quarter ended September 30, 2002. At December
         31, 2001, the costs associated with this application were recorded as
         deferred patent costs. After abandonment, the costs for the CIP patent
         application were deemed by the Company to have no future value and the
         costs were expensed. The total amount paid for the CIP patent
         application was $2,145 and was paid in behalf of the Company by its
         Parent. The Parent by corporate resolution dated September 30, 2002 has
         forgiven the debt. By corporate resolution dated September 30, 2002,
         the Company decided to treat the forgiveness of repayment for the
         $2,145 advanced as a capital contribution.


NOTE 5 - INCOME TAXES

         Income tax expense consists of the following components:

                                                            2002         2001
                                                         ---------    --------
         Current                                         $       -    $      -
         Estimated deferred tax liability (benefits)        (1,355)       (368)
         Less valuation allowance                            1,355         368
                                                         ---------    --------
         Net                                             $       -    $      -
                                                         =========    ========

         At December 31, 2002 and 2001, the Company had net federal operating
         losses (NOL) of $6,628 and $2,273, which can be carried forward to
         offset operating income. The Company's NOL will expire between the
         years 2022 and 2021. Valuation allowances totaling $1,355 and $368 have
         been established for deferred tax assets associated with the above NOL
         for 2002 and 2001 and for the amortizing of organization costs for tax
         purposes for the same periods. The change in the NOL allowances for
         2002 and 2001 was $987 and $368.


NOTE 6 - DEPARTMENT OF ENERGY AWARD

         The Department of Energy (DOE), through its Office of Industrial
         Technologies (OIT) 2000 Inventions and Innovation (I&I) Program awarded
         a grant to the Company during 2001. The Company's application was
         titled "Development of a High-Frequency Eddy-Current Separator". The
         grant was approved in the amount of $199,000.

                                       7
<PAGE>

                            EMPS RESEARCH CORPORATION
                          (Development Stage Companies)

                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)

NOTE 6 - DEPARTMENT OF ENERGY AWARD - CONTINUED

         The grant is a DOE small business grant and thus the Company has no
         financial obligation to DOE under the award. The Company is not
         required to compensate DOE upon successful (or unsuccessful)
         commercialization of a prototype (such as for royalties or
         commissions). As a small business concern the Company prior to entering
         into the award had the option to identify technical data that was
         proprietary and to elect to retain title to this proprietary data. In
         so doing this election, the unlimited right to such technical data by
         DOE was voided per DOE regulations. Per DOE regulations if the Company
         has a "subject invention" related to work done under the award it can
         obtain unlimited rights to the technical data for the "subject
         invention" and has license to use the invention only for government use
         not commercial use. Even so, if proper application and reporting is
         done for the "subject invention" the Company can retain title to the
         "subject invention" and the above rights to DOE to use the invention or
         technical data is voided. It is management's intention to perform the
         proper reporting and application process to retain title to any
         "subject invention" that may arise, if any, during the course of the
         award.

         The project period is from February 1, 2001 to January 31, 2003 and has
         subsequently been extended to December 31, 2003. Specific amounts have
         been subcontracted to two entities to assist in the research to be
         conducted under the grant. During the year ended December 31, 2002 the
         Company had incurred grant expenses in the amount of $77,923. Total
         grant expenses from inception through June 30, 2003 is $140,137.

NOTE 7 - PATENTS

         The cost of the patents being amortized is $2,636. The amortization
         expense for the periods ending June 30, 2003 and December 31, 2002 was
         $103 and $205 respectively. The amortization expense for the next five
         years is anticipated to be the same for each year and that amount is
         $205 per year.

                                       8
<PAGE>

Item 2.  Plan of Operations

         Forward Looking Information and Cautionary Statement

         Certain statements in this quarterly report may be deemed to be
forward-looking statements. Forward-looking statements regarding economic
conditions, effects of corporate initiatives, future profitability, projections,
future revenue opportunities, and their impact on the company are
forward-looking statements and not historical facts. These statements are
estimates or projections involving numerous risks or uncertainties, including
but not limited to, consumer demand, acceptance of services offered by the
company, successful research and development activities, the company's ability
to maintain current expense levels, actions by competitors, impairment of
federal funding, legislative action, student default rates, changes in federal
or state authorization or accreditation changes, changes in market needs and
technology, political or regulatory matters, litigation, general economic
conditions, changes in management strategy and the company's ability to leverage
its curriculum and management infrastructure to build its student base.

         Actual results or events could differ materially from those discussed
in the forward- looking statements. See our report on Forms 10-SB as filed with
the Securities and Exchange Commission for further information. We disclaim any
obligation to publicly update, revise or correct any forward-looking statements,
whether as a result of new information, future events or otherwise.

         The information contained in this analysis should be read in
conjunction with the financial statements contained herein and related
disclosures.

         Overview

         EMPS Research Corporation (the "Company") was incorporated under the
laws of the state of Utah on January 30, 2001, for the purpose of researching
and developing commercial applications for patented technology for a high
frequency eddy current separator, which may be used to separate nonmagnetic
particulate materials from other materials without chemicals, heat or water. The
Company acquired this patented technology from EMPS Corporation, a Nevada
corporation and formerly the parent of the Company. EMPS Corporation acquired
the technology from Particle Separation Technologies, L.C., a Utah limited
liability company. The Company is in the development stage.

                                       9
<PAGE>

         In February, 2001, the Company acquired Patent No. 5,439,117 issued
August 8, 1995, continuation in part Patent No. 5,772,043 issued June 30, 1998
and continuation in part Patent No. 6,095,337 issued on August 1, 2000. The
three patents are titled "System and Method for Separating Electronically
Conductive Particles." The Company received all right, title and interest in and
to the said inventions and patents in exchange for 1,000,000 restricted common
shares of EMPS Research Corporation valued at the patents' book value of $2,636
and EMPS Corporation provided the Company with $2,100 cash and paid
organizational costs of $264.

         On December 23, 2002, the Company filed an amendment to its Articles of
Incorporation effecting a one for three forward stock split resulting in an
increase of the issued and outstanding common stock from 1,000,000 shares to
3,000,000 shares.

         On May 22, 2003, the board of directors of EMPS Corporation, the former
parent of the Company, recommended undertaking a spin-off distribution to its
shareholders of the 3,000,000 common shares of the Company it held. The spin-off
distribution was to be made in conformity with and in reliance upon the
Securities and Exchange Commission (the "Commission") Staff Legal Bulletin 4,
issued by the Commission on September 16, 1997. Both the management of the
Company and EMPS Corporation were in agreement that the spin-off transaction
would benefit both corporations. Since completing its acquisition of Caspian
Service Group, Ltd in July 2002, the major focus of EMPS Corporation has been
the development of the business operations of Caspian Services Group Ltd.
Caspian Services Group Limited, is engaged in the oil and gas services industry
in the oil rich Kazakhstan sector of the Caspian Sea. EMPS Corporation and the
Company's management agreed that the business focuses of the corporations had
become distinct and each would have greater success in their particular industry
if the Company were no longer a subsidiary of EMPS Corporation.

         Management of EMPS Corporation and the Company each believed that a
spin-off would allow the Company to pursue needed financial investment and
attract management assistance suited for a technology development company if the
spin-off were effected. Each corporation would be able to concentrate attention
and financial resources on its respective business activities, without regard to
the objectives and policies of the other business. As independent businesses
each would be able to offer employee incentives tied directly to the results of
the respective business activities. In addition, the spin-off would allow
investors to better evaluate each business, negotiate financing terms focused on
the distinct activities of each business and thereby improve the likelihood that
each corporation would achieve its objectives.

         On May 23, 2003, the majority shareholders of EMPS Corporation approved
the spin-off distribution. The spin-off distribution was completed on August 6,
2003. EMPS Corporation distributed the 3,000,000 shares of Company common stock
it held to the EMPS Corporation shareholders pro-rata on a one share for ten
basis. The EMPS Corporation shareholders paid no consideration for the Company
common shares they received.

         The Company's business activity is focused on continuing research and
development efforts to develop and test prototype equipment derived from the
patents. The Company has primarily funded its research and development
activities from a research grant awarded to the Company from the Department of
Energy's Office of Industrial Technologies 2000 Inventions and Innovation
program. The research grant was received by the Company in January of 2001 in
the amount of one hundred ninety-nine thousand dollars ($199,000). As of June
30, 2003, the Company had spent approximately $140,137 of the grant.

                                       10
<PAGE>

         Plan of Operations

         On or about January 16, 2001, the Company received a research grant in
the amount of $199,000 from the Department of Energy ("DOE"), through its Office
of Industrial Technologies 2000 Inventions and Innovation ("I&I") program for
use in developing an HFECS prototype. The Company recently received approval to
extend the grant period through December 31, 2003.

         Altaire Systems is assisting the Company in designing, fabricating and
assembling the prototype HFECS. Altaire Systems will also be responsible for
field testing and training. Altaire Systems began work on the prototype in
February 2001 and has finished much of the design, fabrication and assembly of
the initial prototype. Based on the work remaining to be completed, the Company
expects Altaire Systems to finish the initial prototype for testing during the
fourth quarter of 2003. The funds to pay Altaire Systems have and will come from
the I&I grant money.

         The Company has retained the University of Utah to test and analyze
equipment design and implementation, test working scale models and perform the
needed data analysis and computer modeling once the prototype is fully
functional. The University of Utah will also assess and develop a plan for
commercializing the technology. For these services, the University of Utah will
receive an estimated total of $104,968. The funds to pay for these services have
and will come from the I&I research grant received by the Company.

         As of June 30, 2003, the Company had spent approximately $140,137 of
the I&I grant money. Of the approximately $58,863 of I&I grant money remaining,
the Company expects to expend $57,319 to the University of Utah, $102 to Altaire
and $1,442 on grant related travel.

         By the end of the fourth quarter of 2003, the Company anticipates that
the prototype will be a fully operational piece of machinery. The Company does
not plan to market or manufacture the equipment. Rather, it plans to research,
develop and test the prototype. If and when testing proves to be successful, the
Company will seek to license the technology for marketing and manufacture. The
Company expects that the prototype will work in smaller commercial settings.

         It is the Company's intent to pursue outside sources through licensing
agreements to market and exploit the commercial applications of this technology.
To date, however, the Company has made limited contacts with outside sources and
no firm commitments or license arrangements are in place.

         The Company believes it can satisfy its current cash requirements for
the next twelve months from the remaining proceeds of the I&I grant and from
funds raised through a private off-shore sale of stock to a non-U.S. person in
December 2002. Thereafter, the Company will need to seek additional funding to
finance operations. To raise additional capital, the Company may have to sell
additional equity securities in accordance with federal and state securities
laws.

                                       11
<PAGE>

The Company may also seek additional funds through debt financing.

         In addition, the Company has been invited by the DOE to make
application for the DOE NICE(3) grant in conjunction with the Utah Engineering
Experiment Station at the University of Utah and the University's industry
partners in Utah. The NICE(3) grant is a cost sharing program for projects that
develop and demonstrate advances in energy efficient and clean production
technologies. To date the Company has not actively pursued this grant. It does,
however, plan to seek an industry partner through the University of Utah and
make application for said grant if and when an industry partner is secured.

Item 3.  Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures. The Company's Chief
Executive Officer and Chief Financial Officer have conducted an evaluation of
the Company's disclosure controls and procedures as of a date (the "Evaluation
Date") within 90 days before the filing of this quarterly report. Based on their
evaluation, the Company's Chief Executive Officer and Chief Financial Officer
have concluded that the Company's disclosure controls and procedures are
effective to ensure that information required to be disclosed by the Company in
reports that it files or submits under the Securities Exchange Act of 1934 is
recorded, processed, summarized and reported within the time periods specified
in the applicable Securities and Exchange Commission rules and forms.

(b) Changes in Internal Controls and Procedures. Subsequent to the Evaluation
Date, there were no significant changes in the Company's internal controls or in
other factors that could significantly affect these controls, nor were any
corrective actions required with regard to significant deficiencies and material
weaknesses.


                           PART II - OTHER INFORMATION

Item 6.  Exhibits and Reports on Form 8-K

         (A) Reports on Form 8-K

                 None.

         (B) Exhibits. The following exhibits are included as part of this
report:

                 Exhibit 31.1   Certification of Principal Executive Officer

                 Exhibit 31.2   Certification of Principal Financial Officer

                 Exhibit 32     Certification Pursuant to Section 906 of the
                                Sarbanes-Oxley Act of 2002

                                       12
<PAGE>

                                   SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this to be signed on its behalf by the undersigned
thereunto duly authorized.

                                               EMPS Research Corporation



August 13, 2003                                By:  /s/ Louis Naegle
                                                   -----------------------------
                                                   Louis Naegle, Principal
                                                   Executive Officer



August 13, 2003                                By: /s/ Timothy L. Adair
                                                   -----------------------------
                                                   Timothy L. Adair,
                                                   Principal Financial Officer

                                       13